Vivos (RDGL) Non-Current Debt (2010 - 2019)

Vivos (RDGL) reported Non-Current Debt of $3.1 million for Q1 2019, little changed sequentially from $3.1 million in Q4 2018.

Vivos (RDGL) Non-Current Debt (2010 - 2019) Analysis & Trends

Vivos (RDGL) has 8 years of Non-Current Debt data on file, last reported at $3.1 million in Q1 2019.

  • For the quarter ending Q1 2019, Non-Current Debt changed N/A year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2019 stood at $3.1 million (changed N/A YoY), and the FY2018 full-year result was $3.1 million, changed N/A from the prior year.
  • Non-Current Debt held at $3.1 million in Q1 2019, from $3.1 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $3.1 million in Q4 2018 to a low of $32279.0 in Q3 2018.
  • A 3-year average of $1.7 million and a median of $1.7 million in 2016 frame the typical range for Non-Current Debt.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 29.64 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 14.22 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 26.17 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 598.50 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 10.13 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 3.18 Bn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 8.07 Bn
10 Vivos 27.16 Mn 25.60 Mn -3,105.00 -

Historic Data

Download Data
DateValue
Mar 31, 2019 3.14 Mn
Dec 31, 2018 3.14 Mn
Sep 30, 2018 32,279.00
Jun 30, 2016 332,195.00
Dec 31, 2014 30,000.00
Dec 31, 2013 70,000.00
Dec 31, 2012 50,000.00
Sep 30, 2012 2,760.00
Jun 30, 2012 10,155.00
Mar 31, 2012 17,354.00
Dec 31, 2011 50,500.00
Dec 31, 2010 50,000.00